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Accumulation of glutamate in synaptic vesicles is mediated by vesicular glutamate transporters called
VGLUTs. In the current issue of Neuron, Preobraschenski et al. (2014) show that the VGLUTs, in addition
to transporting glutamate, also provide the conductances necessary to maintain the appropriate voltage
and pH inside these vesicles.During chemical synaptic transmission,
neurotransmitters accumulate in and are
subsequently released from intracellular
compartments called synaptic vesicles
(SVs). This process is a fundamental
step in neuronal function as well as in
nonneuronal systems. Glutamate is the
major excitatory neurotransmitter, and
therefore, the mechanism of its accu-
mulation into SV is of major interest
to neurobiochemists, neurophysiologists,
and cell biologists. Dysregulation of
glutamate accumulation in SV has been
associated with schizophrenia and epi-
lepsy (Omote et al., 2011). Our genome
encodes for three vesicular glutamate
transporters (VGLUT1–VGLUT3), which
belong to the SLC17 family (Omote
et al., 2011). These transporters utilize
the electrochemical proton gradient
(DmH) created by V-ATPases as the
driving force for glutamate uptake in
the SVs. The H+-pumping activity of the
V-ATPases establishes a pH gradient
(DpH), and in so doing, it also gives rise
to a membrane potential (Dc) (Figure 1).
Interestingly, in addition to its function
as a H+-driven glutamate transporter,
VGLUT2 can also utilize a Na+ gradient
to drive phosphate transport in a gluta-
mate-independent manner (Juge et al.,
2006). In the current issue of Neuron, a
new paper from Preobraschenski et al.
(2014) shows that VGLUTs have yet
other transport function: they mediate
uncoupled Cl movement as well as
K+/H+ exchange.
Since the internal volume of SVs is
small, the presence of uncompensated1110 Neuron 84, December 17, 2014 ª2014charges and unbuffered protons would
generate Dc unfavorable to transport
and drop the vesicular pH below physio-
logical levels, both factors which limit
neurotransmitter accumulation. There-
fore, pathways for the efflux of H+ and
other counterions, mainly Cl and K+,
must exist in SVs to maintain physiolog-
ical levels of pH and charge balance.
While several reports indicated that these
conductances do exist (Goh et al., 2011;
Stobrawa et al., 2001), their molecular
identity remains debated (Schenck et al.,
2009). Among these ions, Cl plays a
key role in regulating neurotransmitter
uptake, acting both as a counterion and
as a regulator of VGLUT activity (Marti-
neau et al., 2013; Schenck et al., 2009;
Stobrawa et al., 2001). However, the
molecular identity of Cl transport path-
way of SVs remains unknown and contro-
versial. An initial report suggested that
the CLC-3 H+/ Cl exchanger might serve
as the main pathway for Cl efflux from
SVs (Stobrawa et al., 2001), but this idea
was later refuted since SVs purified from
CLC-3 knockout mice still retain WT-like
Cl-dependent activity (Martineau et al.,
2013; Omote et al., 2011; Schenck et al.,
2009).
Chloride regulates VGLUT activity in a
complex manner: it is both a stimulator
and an inhibitor of VGLUT-mediated
glutamate uptake into SVs. In the absence
of Cl, transport is completely eliminated,
indicating a strict requirement for this
substrate. As the Cl concentration
rises, transport activity increases sharply,
peaking at 4 mM, and subsequentlyElsevier Inc.decreases again in the presence of high
Cl (Juge et al., 2010; Moriyama and
Yamamoto, 1995; Omote et al., 2011;
Schenck et al., 2009). Although this
phenomenon has been well characterized
functionally, its underlying mechanistic
basis remains poorly understood and
controversial. An initial report indicated
that purified and reconstituted VGLUT1
directly transports Cl, consistent with a
model in which VGLUT plays a dual role.
It provides an efflux pathway for the high
Cl content of freshly endocytosed vesi-
cles, therefore creating the initial driving
force for glutamate uptake before the
V-ATPase has been able to establish
the DpH. Subsequently, VGLUT shunts
the charge accumulation of glutamate
by allowing Cl efflux and maintaining
charge neutrality.
This model was later challenged by
others who showed that purified and re-
constituted VGLUT2 does not directly
mediate Cl transport (Juge et al.,
2010). Since purified VGLUT2 is not
inhibited by high Cl, these authors
also suggested that the decreased
glutamate accumulation seen in native
vesicles arises from an effect of Cl
on the primary V-ATPase rather than
on VGLUT. The steep dependence
of VGLUT activation on Cl suggests
that multiple and highly cooperative
binding sites are present on this trans-
porter. Taken together, these observa-
tions led to the proposal of a competing
model in which Cl is an allosteric regu-
lator of VGLUT activity rather than a
substrate.
Figure 1. The Many Functions of VGLUT
Schematic representation of the energetics of glutamate accumulation in SVs
mediated by VGLUT. The different operational modes of VGLUT are shown on
the right.
Neuron
PreviewsThe stark contrast between
these results belies the
biochemical simplicity of the
reduced systems in which
these experiments were
carried out: purified trans-
porters reconstituted in pro-
teoliposomes. One obvious
possibility accounting for
these discrepancies is that
different VGLUT isoforms
could behave differently with
regards to their ability to
transport Cl. Alternatively,
the interpretation of the data
might be confounded by the
technical difficulties intrinsic
to separating the indirect
effects that H+, K+, and Cl
transport have on VGLUT
through changes in voltage
and pH from their direct
effects on VGLUT itself. In
the current issue of Neuron,Preobraschenski et al. (2014) take on
this controversy in a technical tour de
force and investigate VGLUT-mediated
transport using two systems: in the first,
they use proteoliposomes reconstituted
with purified VGLUT and the F0/F1
ATPase; in the second, they use the
SNARE machinery to fuse purified SVs
and proteoliposomes reconstituted with
the F0/F1 ATPase. These systems allow
Preobraschenski et al. (2014) to investi-
gate VGLUT function in vesicles whose
ionic composition is rigorously controlled
and which either contain a full comple-
ment of correctly oriented native proteins
or just VGLUT and the ATPase. Using
these complementary approaches, they
show that VGLUT alone is necessary
and sufficient to dissipate an outwardly
directed Cl gradient, unambiguously
demonstrating that this protein directly
mediates Cl transport. They show that
VGLUT also has an additional activity: it
can function as a K+/H+ exchanger. In
both types of vesicles, the presence of
K+ gradients leads to the depletion of
the DpH established by the ATPase and
to an increase in Dc, indicating that
VGLUTs mediate transport of both ions.
Surprisingly, neither of these noncanoni-
cal functions of VGLUTs is coupled to
glutamate transport, indicating that these
transporters can operate in several
distinct transport modalities.While the coexistence of multiple
‘‘transport modes’’ by the same protein
is not unprecedented (Adams and
DeFelice, 2003; Artigas and Gadsby,
2003; Fairman et al., 1995), the degree
of functional plasticity displayed by the
VGLUTs is unique. In addition to
their canonical function as glutamate
transporters, these protean transporters
mediate uncoupled Cl movement, K+/
H+ exchange, and Na+-driven phosphate
transport (Figure 1). How a single protein
can adapt to and switch among such
diverse modes is an open question that
will require further work to be elucidated.
In the current manuscript, Preobraschen-
ski et al. (2014) propose a model in
which the VGLUTs have three binding
sites, one cationic and two anionic,
that alternate exposure between the
two sides of the membrane. The location
of these sites is unknown, and their
interaction is remains poorly understood.
Evidence from mutagenesis studies
showed that the glutamate and phos-
phate transport machineries are inde-
pendent (Juge et al., 2006), suggesting
that structurally separate pathways
might exist. It will be interesting to see
whether the VGLUTs can simultaneously
support two or more of these different
transport modes. The intertwined physio-
logical roles of the various functions
together with the independence of theNeuron 84, December 17, 2glutamate and phosphate
transport would be consistent
with the idea that multiple
activities could be carried
out simultaneously. If the
functions are mutually exclu-
sive, then how do VGLUTs
switch between the different
transport modalities? Could
it be as simple as being
determined by which of the
ions or substrate binds first?
Alternatively, it is conceivable
that a more complex con-
formational change might
be required to place these
transporters in the appro-
priate mode.
The physiological implica-
tion of these experiments is
important and surprising: the
VGLUTs alone can provide
all the shunt conductances
necessary for glutamateaccumulation in SVs. This eliminates the
need for any additional components,
other than the V-ATPases, whose role
is to provide the H+ driving force. The
unusual multiplicity of activities carried
out by the VGLUTs allows them to
adapt to the varying ionic conditions
encountered as the SVs change their
ionic content while becoming loaded
with glutamate molecules. The simplicity
of this solution to such a complex
problem is appealing and economical.
While additional experiments will be
needed to determine whether addi-
tional transporters and/or channels con-
tribute to these shunt conductances, the
results obtained by Preobraschenski
et al. (2014) show that these additional
partners are not necessary and that the
VGLUTs are the Swiss army knives of
transporters.REFERENCES
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Gliotransmission, a process involving active vesicular release of glutamate and other neurotransmitters by
astrocytes, is thought to play a critical role in many brain functions. A new paper by Nedergaard et al.
(2014) identifies an experimental flaw in these previous studies suggesting that astrocytes may not perform
active vesicular release after all.Over the past two decades, the role of glia
in the brain has undergone a renaissance
of sorts. These cells, once relegated as
mere passive bystanders of nervous
system development and function, have
garnered new respect as active contribu-
tors to brain physiology. Astrocytes, for
example, had long been thought to exist
for primarily homeostatic roles of clearing
excess synaptic neurotransmitters, main-
taining metabolic balance, and sustaining
the blood brain barrier. A large body of
work, however, soon identified several
predominant roles for astrocytes in active
neurodevelopmental and functional pro-
cesses. These come in multiple facets;
astrocytes are critically required for syn-
apse formation and function, neuronal
migration, synapse phagocytosis, and
even active waste clearance. But these
aspects of astrocytes function in brain
physiology have shared the spotlight
with another tantalizing theory, that astro-
cytes could actively modify synaptic ac-
tivity by the release of ‘‘gliotransmitters.’’
In the early 1990s, fundamental obser-
vations demonstrated that glutamate
could evoke rises in the intracellularcalcium (Ca2+) concentration in cultured
astrocytes and that the increase in Ca2+
concentration in astrocytes could evoke
a Ca2+ response in adjacent neurons
(Cornell-Bell et al., 1990; Nedergaard,
1994). This was an alluring finding,
because it indicated that astrocytes not
only receive information from neurons
but also that they could potentially feed
signals back to neuronal networks. This
idea quickly gained traction and gave
rise to the novel theory of the ‘‘tripartite’’
synapse. This new model proposed that
signal integration and transduction at syn-
apses should be considered in terms of
not only presynaptic and postsynaptic
terminals but also adjacent perisynaptic
astrocytic processes. Since the coining
of this term nearly two decades ago,
over 100 studies have been published
on the role of gliotransmission in normal
brain function. But over time, significant
dissent in the field has questioned the
paradigm of astroglial transmitter release
and modulation of synaptic transmission.
This topic has been reviewed extensively
from perspectives both in favor of astro-
cytic transmitter release (Araque et al.,2014; Halassa and Haydon, 2010) as
well as those to the contrary (Agulhon
et al., 2008; Nedergaard and Verkhratsky,
2012).
The main criticism against astrocytic
transmitter release has been concern
about the nonphysiological nature of
manyof theexperiments in support of glio-
transmition. Most of these studies have
been performed on cultured astrocytes,
raising the question of whether gliotrans-
mitter release actually occurs in vivo.
Perhaps the strongest in vivo evidence in
support of gliotransmissionwas thedevel-
opment of a transgenic mouse line in
which vesicular release could be specif-
ically inhibited in astrocytes. In these
mice, the formation of the SNARE com-
plex between vesicles and the plasma
membrane is inhibited by the expres-
sion of a dominant-negative domain
of the vesicle-associated membrane pro-
tein 2 (VAMP2) protein, which interferes
with endogenous VAMP2 expression and
thus prevents VAMP2-mediated mem-
brane fusion (Pascual et al., 2005). Most
importantly, the glial-fibrillary acidic pro-
tein (GFAP) promoter is used to drive
